SLDB
Solid BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SLDB Profile
Solid Biosciences Inc.
A life sciences company focused on treatments for Duchenne
500 Rutherford Avenue, Third Floor, Charlestown, MA 02129
--
Solid Biosciences Inc., formerly known as SOLID Ventures Management, LLC, was established in March 2013 as a Delaware limited liability company. The Company is a life sciences company focused on advancing a portfolio of current and future gene therapy drug candidates, which the Company refers to collectively as drug candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, or Duchenne, SGT-501 for the treatment of catecholaminergic pleomorphic ventricular tachycardia (CPVT), and additional assets for the treatment of heart and disease, which are at different stages of development with different levels of investment. The company is advancing a diverse pipeline involving rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management and care. Patient-centered and founded by those directly influenced by Duchenne, the company's mission is to improve the daily lives of patients suffering from these devastating diseases.
